小鼠模型技術市場－全球產業規模、佔有率、趨勢、機會和預測，依技術、最終用戶、地區和競爭格局分類，2020-2030年預測

2024年全球小鼠模型技術市場規模為13.5億美元，預計2030年將以10.3%的複合年成長率成長至24.3億美元。小鼠模型技術涵蓋基因改造或近交系小鼠的開發、生產和應用，作為生物醫學研究、藥物發現和毒理學研究的體內工具。推動該市場成長的關鍵因素包括製藥和生物技術領域研發投入的增加、對個人化醫療方法日益成長的需求，以及CRISPR/Cas9等基因工程技術的不斷進步，這些技術能夠實現更精準的疾病建模。

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球小鼠模型技術市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依技術分類（CRISPR基因敲除、隨機插入、大片段標靶插入、ES細胞修飾（同源重組）及其他）
  • 按最終用戶分類（製藥公司、生物技術公司、學術和研究機構、合約研究和生產組織）
  • 按地區
  • 按公司（2024 年）
• 市場地圖

第6章：北美小鼠模型技術市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲小鼠模型技術市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區小鼠模型技術市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲小鼠模型技術市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲小鼠模型技術市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章：市場動態

• 促進要素
• 挑戰

第12章：市場趨勢與發展

• 併購（如有）
• 產品發布（如有）
• 最新進展

第13章：全球小鼠模型技術市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商議價能力
• 顧客的力量
• 替代產品的威脅

第15章：競爭格局

• Biocytogen LLC
• Charles River Laboratories Inc.
• Cyagen Biosciences
• GemPharmatech Co Ltd.
• genOway SA
• Ingenious Targeting Laboratory Inc.
• Merck KGaA.
• Ozgene Pty Ltd.
• Taconic Biosciences Inc.
• Polygena AG

第16章：策略建議

第17章調查會社について,免責事項

The Global Mice Model Technologies Market, valued at USD 1.35 Billion in 2024, is projected to experience a CAGR of 10.3% to reach USD 2.43 Billion by 2030. Mice model technologies encompass the development, production, and application of genetically modified or inbred mouse strains as *in vivo* tools for biomedical research, drug discovery, and toxicology studies. Key drivers supporting this market's growth include increasing research and development investments within the pharmaceutical and biotechnology sectors, the rising demand for personalized medicine approaches, and continuous advancements in genetic engineering techniques such as CRISPR/Cas9, which enable more precise disease modeling.

Key Market Drivers

The escalating global prevalence of chronic diseases acts as a primary catalyst for growth within the mice model technologies market. Conditions such as cancer, diabetes, and neurological disorders necessitate extensive research to elucidate pathogenesis, identify therapeutic targets, and develop effective treatments. Mice models are indispensable tools, providing physiologically relevant *in vivo* systems for disease modeling and drug efficacy testing. The increased burden of these diseases drives demand for specialized mouse models that accurately recapitulate human disease phenotypes. For instance, according to the National Cancer Institute, in an article dated April 4, 2024, "Fiscal Year 2024 Appropriation - NCI", the total appropriation for NCI in fiscal year 2024 was $7.22 billion for cancer research, fueling the application of advanced mouse models crucial for oncology investigations.

Key Market Challenges

A significant challenge impeding the growth of the Global Mice Model Technologies Market is the stringent ethical considerations and regulatory frameworks governing animal welfare in research. These frameworks impose substantial administrative burdens and increased operational costs on research institutions and pharmaceutical companies involved in developing and utilizing mouse models. Navigating complex approval processes for animal studies can extend timelines for drug discovery and toxicology assessments, thereby slowing the development and application of new mouse models.

Key Market Trends

The increasing development of humanized mice models is a significant trend, driven by the need for preclinical tools that more closely mimic human physiology and disease. These models enhance the translational relevance of drug discovery and development, especially in oncology, immunology, and infectious diseases. Charles River Laboratories, in December 2023, highlighted advancements in next-generation humanized models through CRISPR-mediated genetic modification, expanding their utility for immuno-oncology research.

Key Market Players

• Biocytogen LLC
• Charles River Laboratories Inc.
• Cyagen Biosciences
• GemPharmatech Co Ltd.
• genOway S.A.
• Ingenious Targeting Laboratory Inc.
• Merck KGaA.
• Ozgene Pty Ltd.
• Taconic Biosciences Inc.
• Polygena AG

Report Scope:

In this report, the Global Mice Model Technologies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Mice Model Technologies Market, By Technology:

• CRISPR Knockout
• Random Insertions
• Large and Targeted Insertions
• ES Cell Modification (Homologous Recombination)
• Others

Mice Model Technologies Market, By End Users:

• Pharmaceutical Companies
• Biotechnology Companies
• Academic and Research Facilities
• Contract Research and Manufacturing Organizations

Mice Model Technologies Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Mice Model Technologies Market.

Available Customizations:

Global Mice Model Technologies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Mice Model Technologies Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technology (CRISPR Knockout, Random Insertions, Large and Targeted Insertions, ES Cell Modification (Homologous Recombination), Others)
  • 5.2.2. By End Users (Pharmaceutical Companies, Biotechnology Companies, Academic and Research Facilities, Contract Research and Manufacturing Organizations)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Mice Model Technologies Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technology
  • 6.2.2. By End Users
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Mice Model Technologies Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technology
      • 6.3.1.2.2. By End Users
  • 6.3.2. Canada Mice Model Technologies Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technology
      • 6.3.2.2.2. By End Users
  • 6.3.3. Mexico Mice Model Technologies Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technology
      • 6.3.3.2.2. By End Users

7. Europe Mice Model Technologies Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technology
  • 7.2.2. By End Users
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Mice Model Technologies Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technology
      • 7.3.1.2.2. By End Users
  • 7.3.2. France Mice Model Technologies Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technology
      • 7.3.2.2.2. By End Users
  • 7.3.3. United Kingdom Mice Model Technologies Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technology
      • 7.3.3.2.2. By End Users
  • 7.3.4. Italy Mice Model Technologies Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technology
      • 7.3.4.2.2. By End Users
  • 7.3.5. Spain Mice Model Technologies Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technology
      • 7.3.5.2.2. By End Users

8. Asia Pacific Mice Model Technologies Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technology
  • 8.2.2. By End Users
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Mice Model Technologies Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technology
      • 8.3.1.2.2. By End Users
  • 8.3.2. India Mice Model Technologies Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technology
      • 8.3.2.2.2. By End Users
  • 8.3.3. Japan Mice Model Technologies Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technology
      • 8.3.3.2.2. By End Users
  • 8.3.4. South Korea Mice Model Technologies Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technology
      • 8.3.4.2.2. By End Users
  • 8.3.5. Australia Mice Model Technologies Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technology
      • 8.3.5.2.2. By End Users

9. Middle East & Africa Mice Model Technologies Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technology
  • 9.2.2. By End Users
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Mice Model Technologies Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technology
      • 9.3.1.2.2. By End Users
  • 9.3.2. UAE Mice Model Technologies Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technology
      • 9.3.2.2.2. By End Users
  • 9.3.3. South Africa Mice Model Technologies Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technology
      • 9.3.3.2.2. By End Users

10. South America Mice Model Technologies Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technology
  • 10.2.2. By End Users
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Mice Model Technologies Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technology
      • 10.3.1.2.2. By End Users
  • 10.3.2. Colombia Mice Model Technologies Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technology
      • 10.3.2.2.2. By End Users
  • 10.3.3. Argentina Mice Model Technologies Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technology
      • 10.3.3.2.2. By End Users

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Mice Model Technologies Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Biocytogen LLC
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Charles River Laboratories Inc.
• 15.3. Cyagen Biosciences
• 15.4. GemPharmatech Co Ltd.
• 15.5. genOway S.A.
• 15.6. Ingenious Targeting Laboratory Inc.
• 15.7. Merck KGaA.
• 15.8. Ozgene Pty Ltd.
• 15.9. Taconic Biosciences Inc.
• 15.10. Polygena AG

16. Strategic Recommendations

17. About Us & Disclaimer